Diabetes Mellitus and Optic Atrophy: A Study of Wolfram Syndrome in the Lebanese Population
Open Access
- 1 April 2004
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 89 (4), 1656-1661
- https://doi.org/10.1210/jc.2002-030015
Abstract
Wolfram syndrome (WFS) is a rare hereditary neurodegenerative disorder also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness). WFS seems to be a heterogeneous disease that has not yet been fully characterized in terms of clinical features and pathophysiological mechanisms because the number of patients in most series was small. In this study we describe 31 Lebanese WFS patients belonging to 17 families; this, to our knowledge, is the largest number of patients reported in one series so far. Criteria for diagnosis of WFS were the presence of insulin-dependent diabetes mellitus and optic atrophy unexplained by any other disease. Central diabetes insipidus was found in 87% of the patients, and sensorineural deafness confirmed by audiograms was present in 64.5%. Other less frequent features included neurological and psychiatric abnormalities, urodynamic abnormalities, limited joint motility, cardiovascular and gastrointestinal autonomic neuropathy, hypergonadotropic hypogonadism in males, and diabetic microvascular disease. New features, not reported in previous descriptions, such as heart malformations and anterior pituitary dysfunction, were recognized in some of the patients and participated in the morbidity and mortality of the disease. Genetic analysis revealed WFS1 gene mutations in three families (23.5%), whereas no abnormalities were detected in mitochondrial DNA. In conclusion, WFS is a devastating disease for the patients and their families. More information about WFS will lead to a better understanding of this disease and hopefully to improvement in means of its prevention and treatment.Keywords
This publication has 34 references indexed in Scilit:
- Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients.Diabetes Care, 1999
- Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome familyHuman Genetics, 1998
- A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)Nature Genetics, 1998
- Wolfram (DIDMOAD) Syndrome and Leber Hereditary Optic Neuropathy (LHON) Are Associated with Distinct Mitochondrial DNA HaplotypesGenomics, 1997
- A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome.JCI Insight, 1996
- Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndromeThe Lancet, 1995
- Morbidity and Mortality in the Wolfram SyndromeDiabetes Care, 1995
- Renal Failure in Wolfram's SyndromeDiabetes Care, 1993
- Mitochondrial abnormalities in the DIDMOAD syndromeJournal of Inherited Metabolic Disease, 1992
- Juvenile diabetes mellitus, optic atrophy, sensory nerve deafness, and diabetes insipidus—a syndromeThe Journal of Pediatrics, 1976